Plant ID: NPO3037
Plant Latin Name: Derris indica
Taxonomy Genus: Derris
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
India
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 9.052E-14 | 1.971E-09 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 2.789E-10 | 3.036E-06 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 8.948E-10 | 6.494E-06 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 6.403E-09 | 2.451E-05 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 6.403E-09 | 2.451E-05 | CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 6.754E-09 | 2.451E-05 | CYP2C19, CYP2C9, CYP2D6, CYP3A4, NPC1 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 3.973E-08 | 8.651E-05 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 6.340E-08 | 1.151E-04 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0016705; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.370E-07 | 2.131E-04 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.557E-07 | 2.260E-04 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 3.377E-07 | 4.595E-04 | CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 6.752E-07 | 8.168E-04 | CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 5.059E-06 | 4.213E-03 | CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0006082; organic acid metabolic process | 6.038E-06 | 4.696E-03 | ABCG2, CYP2C19, CYP2C9, CYP2D6, NPC1 |
BP | GO:0008152; metabolic process | GO:0032787; monocarboxylic acid metabolic process | 1.232E-05 | 9.240E-03 | CYP2C19, CYP2C9, CYP2D6, NPC1 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 4.736E-05 | 2.578E-02 | ABCG2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, NPC1 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 1.601E-04 | 6.972E-02 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
CC | GO:0043226; organelle | GO:0043231; intracellular membrane-bounded organelle | 1.759E-03 | 4.286E-01 | ABCG2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, MAPT, NPC1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 4.505E-09 | 6.757E-08 | CYP2C9, CYP2D6, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 9.556E-08 | 7.167E-07 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.616E-06 | 8.079E-06 | CYP2C9, CYP2D6, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 5.887E-06 | 1.766E-05 | CYP2C9, CYP2D6, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.298E-06 | 8.616E-06 | CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.966E-04 | 4.631E-04 | CYP2C9, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.161E-04 | 4.631E-04 | CYP2C9, CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 2.580E-04 | 4.837E-04 | CYP3A4, ABCG2 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 6.873E-03 | 1.146E-02 | CYP2C9, CYP2C19, CYP3A4 |
09130 Environmental Information Processing | 09131 Membrane transport | hsa02010 | ABC transporters | 1.530E-02 | 2.181E-02 | ABCG2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |